MEDICAL FACILITIES CORP (DR.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:DR - CA58457V5036 - Common Stock
15.95 CAD
+0.19 (+1.21%)
Taking everything into account, DR scores 7 out of 10 in our fundamental rating. DR was compared to 15 industry peers in the Health Care Providers & Services industry. DR gets an excellent profitability rating and is at the same time showing great financial health properties. DR is cheap, but on the other hand it scores bad on growth. These ratings would make DR suitable for value investing!
1. Profitability
1.1 Basic Checks
- DR had positive earnings in the past year.
- In the past year DR had a positive cash flow from operations.
- Of the past 5 years DR 4 years were profitable.
- Each year in the past 5 years DR had a positive operating cash flow.
1.2 Ratios
- DR has a Return On Assets of 30.18%. This is amongst the best in the industry. DR outperforms 93.33% of its industry peers.
- The Return On Equity of DR (94.43%) is better than 100.00% of its industry peers.
- With an excellent Return On Invested Capital value of 15.42%, DR belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for DR is significantly above the industry average of 6.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.18% | ||
| ROE | 94.43% | ||
| ROIC | 15.42% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
1.3 Margins
- The Profit Margin of DR (31.60%) is better than 93.33% of its industry peers.
- DR's Profit Margin has improved in the last couple of years.
- DR's Operating Margin of 15.59% is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
- DR's Operating Margin has been stable in the last couple of years.
- DR has a better Gross Margin (63.75%) than 86.67% of its industry peers.
- In the last couple of years the Gross Margin of DR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 31.6% | ||
| GM | 63.75% |
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DR is creating value.
- Compared to 1 year ago, DR has less shares outstanding
- Compared to 5 years ago, DR has less shares outstanding
- DR has a better debt/assets ratio than last year.
2.2 Solvency
- DR has an Altman-Z score of 1.37. This is a bad value and indicates that DR is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.37, DR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
- The Debt to FCF ratio of DR is 2.05, which is a good value as it means it would take DR, 2.05 years of fcf income to pay off all of its debts.
- DR has a better Debt to FCF ratio (2.05) than 93.33% of its industry peers.
- A Debt/Equity ratio of 1.02 is on the high side and indicates that DR has dependencies on debt financing.
- With a Debt to Equity ratio value of 1.02, DR perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
- Even though the debt/equity ratio score it not favorable for DR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.05 | ||
| Altman-Z | 1.37 |
ROIC/WACC1.81
WACC8.51%
2.3 Liquidity
- A Current Ratio of 1.79 indicates that DR should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.79, DR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- A Quick Ratio of 1.67 indicates that DR should not have too much problems paying its short term obligations.
- DR's Quick ratio of 1.67 is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
- DR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.81%, which is quite impressive.
- DR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.68%.
- The Revenue has been decreasing by -3.59% on average over the past years.
EPS 1Y (TTM)60.81%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%-23.33%
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%
3.2 Future
- The Earnings Per Share is expected to grow by 10.76% on average over the next years. This is quite good.
- The Revenue is expected to decrease by -7.10% on average over the next years.
EPS Next Y34.23%
EPS Next 2Y14.43%
EPS Next 3Y10.76%
EPS Next 5YN/A
Revenue Next Year-20.98%
Revenue Next 2Y-10.85%
Revenue Next 3Y-7.1%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 9.67, the valuation of DR can be described as reasonable.
- Based on the Price/Earnings ratio, DR is valued cheaper than 86.67% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.54, DR is valued rather cheaply.
- DR is valuated reasonably with a Price/Forward Earnings ratio of 9.32.
- Based on the Price/Forward Earnings ratio, DR is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 24.31. DR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.67 | ||
| Fwd PE | 9.32 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
- DR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DR is cheaper than 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.24 | ||
| EV/EBITDA | 4.56 |
4.3 Compensation for Growth
- DR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- DR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y14.43%
EPS Next 3Y10.76%
5. Dividend
5.1 Amount
- DR has a Yearly Dividend Yield of 2.26%.
- Compared to an average industry Dividend Yield of 1.30, DR pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.92, DR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
5.2 History
- The dividend of DR decreases each year by -19.91%.
- DR has been paying a dividend for at least 10 years, so it has a reliable track record.
- DR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.91%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
- DR pays out 6.72% of its income as dividend. This is a sustainable payout ratio.
DP6.72%
EPS Next 2Y14.43%
EPS Next 3Y10.76%
TSX:DR (1/15/2026, 7:00:00 PM)
15.95
+0.19 (+1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-11 2026-03-11
Inst Owners11.96%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap287.90M
Revenue(TTM)257.36M
Net Income(TTM)81.33M
Analysts40
Price Target16.58 (3.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
Yearly Dividend0.35
Dividend Growth(5Y)-19.91%
DP6.72%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.6%
Min EPS beat(2)-7.54%
Max EPS beat(2)6.33%
EPS beat(4)2
Avg EPS beat(4)3.38%
Min EPS beat(4)-24.98%
Max EPS beat(4)39.71%
EPS beat(8)3
Avg EPS beat(8)-25.78%
EPS beat(12)5
Avg EPS beat(12)32.86%
EPS beat(16)7
Avg EPS beat(16)-103.27%
Revenue beat(2)1
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-4.5%
Max Revenue beat(2)1.91%
Revenue beat(4)1
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-18.84%
Max Revenue beat(4)1.91%
Revenue beat(8)3
Avg Revenue beat(8)-3.49%
Revenue beat(12)4
Avg Revenue beat(12)-2.43%
Revenue beat(16)5
Avg Revenue beat(16)-2.23%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.63%
EPS NY rev (1m)0%
EPS NY rev (3m)1.24%
Revenue NQ rev (1m)1.55%
Revenue NQ rev (3m)3.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.67 | ||
| Fwd PE | 9.32 | ||
| P/S | 0.8 | ||
| P/FCF | 4.24 | ||
| P/OCF | 3.9 | ||
| P/B | 2.4 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.56 |
EPS(TTM)1.65
EY10.34%
EPS(NY)1.71
Fwd EY10.73%
FCF(TTM)3.76
FCFY23.6%
OCF(TTM)4.09
OCFY25.64%
SpS19.82
BVpS6.63
TBVpS-0.87
PEG (NY)0.28
PEG (5Y)N/A
Graham Number15.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.18% | ||
| ROE | 94.43% | ||
| ROCE | 18.66% | ||
| ROIC | 15.42% | ||
| ROICexc | 19.71% | ||
| ROICexgc | 46.81% | ||
| OM | 15.59% | ||
| PM (TTM) | 31.6% | ||
| GM | 63.75% | ||
| FCFM | 18.99% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
ROICexc(3y)21.7%
ROICexc(5y)18.79%
ROICexgc(3y)53.59%
ROICexgc(5y)43.79%
ROCE(3y)19.81%
ROCE(5y)17.76%
ROICexgc growth 3Y35.06%
ROICexgc growth 5Y23.36%
ROICexc growth 3Y18.42%
ROICexc growth 5Y13.1%
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
F-Score6
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.05 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 25.03% | ||
| Cap/Sales | 1.64% | ||
| Interest Coverage | 7.65 | ||
| Cash Conversion | 93.1% | ||
| Profit Quality | 60.09% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 1.37 |
F-Score6
WACC8.51%
ROIC/WACC1.81
Cap/Depr(3y)47.79%
Cap/Depr(5y)40.36%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.81%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%-23.33%
EPS Next Y34.23%
EPS Next 2Y14.43%
EPS Next 3Y10.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%
Revenue Next Year-20.98%
Revenue Next 2Y-10.85%
Revenue Next 3Y-7.1%
Revenue Next 5YN/A
EBIT growth 1Y-46.1%
EBIT growth 3Y-6.86%
EBIT growth 5Y-4.85%
EBIT Next Year2.39%
EBIT Next 3Y1.85%
EBIT Next 5YN/A
FCF growth 1Y-6.31%
FCF growth 3Y4.28%
FCF growth 5Y3.38%
OCF growth 1Y-24.65%
OCF growth 3Y3.26%
OCF growth 5Y1.55%
MEDICAL FACILITIES CORP / DR.CA FAQ
What is the fundamental rating for DR stock?
ChartMill assigns a fundamental rating of 7 / 10 to DR.CA.
Can you provide the valuation status for MEDICAL FACILITIES CORP?
ChartMill assigns a valuation rating of 9 / 10 to MEDICAL FACILITIES CORP (DR.CA). This can be considered as Undervalued.
Can you provide the profitability details for MEDICAL FACILITIES CORP?
MEDICAL FACILITIES CORP (DR.CA) has a profitability rating of 8 / 10.
What is the expected EPS growth for MEDICAL FACILITIES CORP (DR.CA) stock?
The Earnings per Share (EPS) of MEDICAL FACILITIES CORP (DR.CA) is expected to grow by 34.23% in the next year.
How sustainable is the dividend of MEDICAL FACILITIES CORP (DR.CA) stock?
The dividend rating of MEDICAL FACILITIES CORP (DR.CA) is 5 / 10 and the dividend payout ratio is 6.72%.